Similar prevalence of founder BRCA1 and BRCA2 mutations among Ashkenazi and non-Ashkenazi men with breast cancer: Evidence from 261 cases in Israel, 1976-1999

European Journal of Medical Genetics

Volumn 51, Issue 2, 2008, Pages 141-147

  Chodick, Gabriel ^a   Struewing, Jeffery P ^a   Ron, Elaine ^a   Rutter, Joni L ^a   Iscovich, Jose ^b,c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Selikoff Center for Environmental Health and Human Development   (Israel)

^c Former at the International Fertility Institute   (Israel)

Author keywords

BRCA1 mutation; BRCA2 mutation; Epidemiology; Israel; Male breast cancer

Indexed keywords

ADULT; AGED; ANALYTIC METHOD; ARTICLE; BRCA2 GENE; BREAST CANCER; CANCER DIAGNOSIS; CANCER SCREENING; CONTROLLED STUDY; GENE; GENE MUTATION; HETEROZYGOTE; HUMAN; ISRAEL; MAJOR CLINICAL STUDY; MALE; MUTATION RATE; ONCOGENE; PREVALENCE;

ADULT; AGED; AGED, 80 AND OVER; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS, MALE; FOUNDER EFFECT; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GERM-LINE MUTATION; HUMANS; ISRAEL; JEWS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS;

EID: 40649098015     PISSN: 17697212     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejmg.2007.11.001     Document Type: Article

References (31)

1. Jemal A., Murray T., Ward E., Samuels A., Tiwari R.C., Ghafoor A., et al. Cancer statistics, 2005. CA Cancer J. Clin. 55 (2005) 10-30
2. Giordano S.H., Cohen D.S., Buzdar A.U., Perkins G., and Hortobagyi G.N. Breast carcinoma in men: a population-based study. Cancer 101 (2004) 51-57
3. Brenner B., Fried G., Levitzki P., Rakowsky E., Lurie H., Idelevich E., et al. Male breast carcinoma in Israel: higher incidence but possibly better prognosis in Ashkenazi Jews. Cancer 94 (2002) 2128-2133
4. Israel Central Bureau of Statistics. Statistical Abstracts of Israel No. 56 (2005), Israel Central Bureau of Statistics, Jerusalem, Israel
5. Mabuchi K., Bross D.S., and Kessler I.I. Risk factors for male breast cancer. J. Natl. Cancer Inst. 74 (1985) 371-375
6. Schottenfeld D., Lilienfeld A.M., and Diamond H. Some observations on the epidemiology of breast cancer among males. Am. J. Public Health 53 (1963) 890-897
7. Schottenfeld D., and Lilienfeld A.M. Some epidemiological features of breast cancer among males. J. Chronic Dis. 16 (1963) 71-81
8. Keller A.Z. Demographic, clinical and survivorship characteristics of males with primary cancer of the breast. Am. J. Epidemiol. 85 (1967) 183-199
9. Satagopan J., Offit K., Foulkes W.D., Robson M., Wacholder S., Eng C., et al. The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations. Cancer Epidemiol. Biomarkers Prev. 10 (2001) 467-473
10. Struewing J., Hartge P., Wacholder S., Baker S., Berlin M., McAdams M., et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N. Engl. J. Med. 336 (1997) 1401-1408
11. Tonin P., Weber B., Offit K., Couch F., Rebbeck T.R., Neuhausen S., et al. Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nat. Med. 2 (1996) 1179-1183
12. Struewing J., Coriaty Z., Livoff A., Konichezky M., Cohn P., Resnick M., et al. Founder BRCA1/2 mutations among male patients with breast cancer in Israel. Am. J. Hum. Genet. 650 (1999) 1800-1802
13. Bar-Sade R., Kruglikova A., Modan B., Gak E., Hirsh-Yechezkel G., Theodor L., et al. The 185delAG BRCA1 mutation originated before the dispersion of Jews in the diaspora and is not limited to Ashkenazim. Hum. Mol. Genet. 7 (1998) 801-805
14. Frank T.S., Deffenbaugh A.M., Reid J.E., Hulick M., Ward B.E., Lingenfelter B., et al. Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J. Clin. Oncol. 15 (2002) 1480-1490
15. Sverdlov R.S., Barshack I., Bar Sade R.B., Baruch R.G., Hirsh-Yehezkel G., Dagan E., et al. Genetic analyses of male breast cancer in Israel. Genet. Test. 4 (2000) 313-317
16. Israel National Cancer Registry. Annual Reports. Available from: (2005). http://www.health.gov.il/
17. Ottini L., Masala G., D'Amico C., Mancini B., Saieva C., Aceto G., et al. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy. Cancer Res. 63 (2003) 342-347
18. Friedman L., Gayther S., Kurosaki T., Gordon D., Noble B., Casey G., et al. Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. Am. J. Hum. Genet. 60 (1997) 313-319
19. Csokay B., Udvarhelyi N., Sulyok Z., Besznyak I., Ramus S., Ponder B., et al. High frequency of germ-line BRCA2 mutations among Hungarian male breast cancer patients without family history. Cancer Res. 59 (1999) 995-998
20. Tirkkonen M., Kainu T., Loman N., Johannsson O., Olsson H., Barkardottir R., et al. Somatic genetic alterations in BRCA2-associated and sporadic male breast cancer. Genes Chromosomes Cancer 24 (1999) 56-61
21. Basham V., Lipscombe J., Ward J., Gayther S., Ponder B., Easton D., et al. BRCA1 and BRCA2 mutations in a population-based study of male breast cancer. Breast Cancer Res. 4 (2002) R2
22. Haraldsson K., Loman N., Zhang Q., Johannsson O., Olsson H., and Borg A. BRCA2 germ-line mutations are frequent in male breast cancer patients without a family history of the disease. Cancer Res. 58 (1998) 1367-1371
23. Thorlacius S., Sigurdsson S., Bjarnadottir H., Olafsdottir G., Jonasson J., Tryggvadottir L., et al. Study of a single BRCA2 mutation with high carrier frequency in a small population. Am. J. Hum. Genet. 60 (1997) 1079-1084
24. Couch F., Farid L., DeShano M., Tavtigian S., Calzone K., Campeau L., et al. BRCA2 germline mutations in male breast cancer cases and breast cancer families. Nat. Genet. 13 (1996) 123-125
25. Kwiatkowska E., Teresiak M., Lamperska K., Karczewska A., Breborowicz D., Stawicka M., et al. BRCA2 germline mutations in male breast cancer patients in the Polish population. Hum. Mutat. 17 (2001) 73
26. Antoniou A., Pharoah P.D., Narod S., Risch H.A., Eyfjord J.E., Hopper J.L., et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am. J. Hum. Genet. 72 (2003) 1117-1130
27. Yaffe N., and Tal D. Immigration to Israel from the Former Soviet Union. Available from: (2001).
28. Szabo C., and King M. Population genetics of BRCA1 and BRCA2. Am. J. Hum. Genet. 60 (1997) 1013-1020
29. Loginova A., Pospekhova N., Lyubchenko L., Budilov A., Zakhar'ev V., Gar'kavtseva R., et al. Spectrum of mutations in BRCA1 gene in hereditary forms of breast and ovarian cancer in Russian families. Bull. Exp. Biol. Med. 136 (2003) 276-278
30. Gorski B., Byrski T., Huzarski T., Jakubowska A., Menkiszak J., Gronwald J., et al. Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer. Am. J. Hum. Genet. 66 (2000) 1963-1968
31. Israel Central Bureau of Statistics. Statistical Abstract of Israel No. 57. Available from: (2006).